Test of a gel for nerve pain after chemotherapy
Part of Brain & nervous system, Kidney & urinary, Pain, Women’s health & pregnancy clinical trials.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had chemotherapy for cancer and are now in remission, with moderate nerve pain in your hands or feet for at least 3 months.
- You are between 18 and 80 years old.
- Your average daily pain score over 4 days is between 4 and 8 out of 10.
- You are able to apply the study gel on your own.
- You agree to only use paracetamol (Tylenol) for extra pain and to follow all study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “TRP channels,” which are part of how nerves sense pain and temperature, to understand nerve pain (neuropathy) after chemotherapy. It may help improve how future treatments prevent or reduce nerve pain in people who have had certain chemotherapy drugs.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
This study tests whether remote check-ins (via phone/app/website) can help manage chemotherapy-related nerve pain in the hands and feet. It enrolls adults who developed nerve symptoms after certain cancer medicines and need ongoing monitoring.
This study tests whether a small device that sends gentle electrical pulses to nerves in your leg can relieve pain caused by chemotherapy. If you have ongoing nerve pain in your legs from past chemo, this treatment might offer a new way to manage it.
This trial tests a small device you wear on your ear to see if it can reduce nerve pain caused by chemotherapy (CIPN). You use it yourself at home, and it may help with the tingling, numbness, or burning in your hands and feet.
This trial looks at whether light (photobiomodulation) and laser-like therapy can reduce nerve pain in people who developed neuropathy after chemotherapy. If you match the chemotherapy and language requirements, you may be screened to see if this treatment is safe and helpful for your symptoms.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.